- $253.26m
- $85.19m
- 26
- 20
- 43
- 20
Annual balance sheet for Kodiak Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 969 | 732 | 479 | 286 | 168 |
| Prepaid Expenses | |||||
| Total Current Assets | 972 | 735 | 486 | 289 | 172 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 78.8 | 108 | 116 | 175 | 149 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,067 | 904 | 667 | 479 | 336 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 31.4 | 64.7 | 52.5 | 41.7 | 25.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 207 | 241 | 230 | 214 | 185 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 861 | 663 | 436 | 266 | 150 |
| Total Liabilities & Shareholders' Equity | 1,067 | 904 | 667 | 479 | 336 |
| Total Common Shares Outstanding |